Julie Schneider to Ethylene Glycols
This is a "connection" page, showing publications Julie Schneider has written about Ethylene Glycols.
Connection Strength
0.694
-
Theoretical impact of Florbetapir (18F) amyloid imaging on diagnosis of alzheimer dementia and detection of preclinical cortical amyloid. J Neuropathol Exp Neurol. 2014 Oct; 73(10):948-53.
Score: 0.123
-
Neuropathologic heterogeneity does not impair florbetapir-positron emission tomography postmortem correlates. J Neuropathol Exp Neurol. 2014 Jan; 73(1):72-80.
Score: 0.117
-
Positive florbetapir PET amyloid imaging in a subject with frequent cortical neuritic plaques and frontotemporal lobar degeneration with TDP43-positive inclusions. J Alzheimers Dis. 2014; 42(3):813-21.
Score: 0.117
-
Cerebral PET with florbetapir compared with neuropathology at autopsy for detection of neuritic amyloid-? plaques: a prospective cohort study. Lancet Neurol. 2012 Aug; 11(8):669-78.
Score: 0.105
-
Correlation of amyloid PET ligand florbetapir F 18 binding with A? aggregation and neuritic plaque deposition in postmortem brain tissue. Alzheimer Dis Assoc Disord. 2012 Jan-Mar; 26(1):8-16.
Score: 0.101
-
Use of florbetapir-PET for imaging beta-amyloid pathology. JAMA. 2011 Jan 19; 305(3):275-83.
Score: 0.095
-
Genetic epistasis regulates amyloid deposition in resilient aging. Alzheimers Dement. 2017 Oct; 13(10):1107-1116.
Score: 0.036